Today, the head of the Ministry of Industry and Trade Denis Manturov and the Mayor of Moscow Sergey Sobyanin launched production at the new pharmaceutical plant "R-Opra." The modern enterprise is located in the special economic zone "Technopolis Moscow" in Zelenograd.
According to Manturov, the company's capacity is 270 million packages of drugs per year.
I am confident that in the near future, when R-Opra starts producing its products for civilian use, doctors and patients will appreciate the quality and availability of domestic medicines - as early as 2024, anti-cancer drugs produced at this plant will be released into circulation.
R-Opra will produce drugs for the therapy of oncological and orphan diseases, respiratory, rheumatic, cardiovascular, neurological and nephrological diseases, for the therapy of HIV infection, as well as immunosuppressants.
As for dosage forms, the plant will produce drugs in the form of tablets, in the form of sterile solutions and lyophilisates, as well as in soft gelatin capsules and powders for inhalation in capsules.
The enterprise uses controllers and components from a Russian manufacturer to automate engineering systems, and the system for monitoring climatic parameters in production is implemented on a hardware and software complex from a domestic company.
Together with the Ministry of Industry, we set a goal five years ago to maximize the localization of the production of imported drugs in Russia, to move away from imports, especially when it comes to vital medicines in the field of oncology.
